BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 16814369)

  • 1. Metabolic regulation and chemotherapy.
    Weber G
    Adv Enzyme Regul; 2006; 46():26-32. PubMed ID: 16814369
    [No Abstract]   [Full Text] [Related]  

  • 2. Modulation of cancer pathways by inhibitors of guanylate metabolism.
    Oláh E; Kökény S; Papp J; Bozsik A; Keszei M
    Adv Enzyme Regul; 2006; 46():176-90. PubMed ID: 16857242
    [No Abstract]   [Full Text] [Related]  

  • 3. Biochemical strategy of cancer cells and the design of chemotherapy: G. H. A. Clowes Memorial Lecture.
    Weber G
    Cancer Res; 1983 Aug; 43(8):3466-92. PubMed ID: 6305486
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis of novel ribavirin hydrazone derivatives and anti-proliferative activity against A549 lung cancer cells.
    Liu WY; Li HY; Zhao BX; Shin DS; Lian S; Miao JY
    Carbohydr Res; 2009 Jul; 344(11):1270-5. PubMed ID: 19527904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The normal metabolism of uric acid.
    Cartier P; Hamet M
    Adv Nephrol Necker Hosp; 1974; 3():3-28. PubMed ID: 4377518
    [No Abstract]   [Full Text] [Related]  

  • 6. 2-(3-Amino-3-deoxy-beta-D-xylofuranosyl)thiazole-4-carboxamide: a new tiazofurin analogue with potent antitumour activity.
    Popsavin M; Spaić S; Svircev M; Kojić V; Bogdanović G; Popsavin V
    Bioorg Med Chem Lett; 2006 Oct; 16(20):5317-20. PubMed ID: 16908146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and antitumour activity of new tiazofurin analogues bearing a 2,3-anhydro functionality in the furanose ring.
    Popsavin M; Spaić S; Svircev M; Kojić V; Bogdanović G; Popsavin V
    Bioorg Med Chem Lett; 2007 Aug; 17(15):4123-7. PubMed ID: 17543526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of 2-pyrrolepolyamide-2'-deoxyguanosine 5'-phosphate.
    Kawashima E; Nakanishi Y; Terui Y; Tomitori H; Kashiwagi K; Ohba Y; Kamaike K
    Nucleic Acids Symp Ser (Oxf); 2007; (51):263-4. PubMed ID: 18029687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three new asymmetric trans-amine(azole)dichloridoplatinum complexes that overcome cisplatin resistance and their reactions with 5'-GMP.
    Pantoja E; Gallipoli A; van Zutphen S; Komeda S; Reddy D; Jaganyi D; Lutz M; Tooke DM; Spek AL; Navarro-Ranninger C; Reedijk J
    J Inorg Biochem; 2006 Dec; 100(12):1955-64. PubMed ID: 17083978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and antitumor activities investigation of a C-nucleoside analogue of ribavirin.
    Sabat N; Migianu-Griffoni E; Tudela T; Lecouvey M; Kellouche S; Carreiras F; Gallier F; Uziel J; Lubin-Germain N
    Eur J Med Chem; 2020 Feb; 188():112009. PubMed ID: 31883488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ribavirin enhances interferon signaling via stimulation of mTOR and p53 activities.
    Su WC; Liu WL; Cheng CW; Chou YB; Hung KH; Huang WH; Wu CL; Li YT; Shiau AL; Lai MY
    FEBS Lett; 2009 Sep; 583(17):2793-8. PubMed ID: 19619545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of in-vitro models of chemotherapy resistance.
    Watson MB; Lind MJ; Cawkwell L
    Anticancer Drugs; 2007 Aug; 18(7):749-54. PubMed ID: 17581296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sir Hans A. Krebs Centenary Lecture: cancer and clinical targeting.
    Weber G
    Adv Enzyme Regul; 2001; 41():1-29. PubMed ID: 11417529
    [No Abstract]   [Full Text] [Related]  

  • 14. [Molecular mechanism of cell death induced by chemotherapeutic agents].
    Saya H
    Brain Nerve; 2009 Jul; 61(7):843-7. PubMed ID: 19618862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and anti-tumor evaluation of novel symmetrical bis-benzimidazoles.
    Yang YH; Cheng MS; Wang QH; Nie H; Liao N; Wang J; Chen H
    Eur J Med Chem; 2009 Apr; 44(4):1808-12. PubMed ID: 18762358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can mutations in gamma-actin modulate the toxicity of microtubule targeting agents?
    Fojo T
    J Natl Cancer Inst; 2006 Oct; 98(19):1345-7. PubMed ID: 17018774
    [No Abstract]   [Full Text] [Related]  

  • 17. SAR of a novel 'Anthranilamide Like' series of VEGFR-2, multi protein kinase inhibitors for the treatment of cancer.
    Wickens P; Kluender H; Dixon J; Brennan C; Achebe F; Bacchiocchi A; Bankston D; Bierer D; Brands M; Braun D; Brown MS; Chuang CY; Dumas J; Enyedy I; Hofilena G; Hong Z; Housley T; Jones B; Khire U; Kreiman C; Kumarasinghe E; Lowinger T; Ott-Morgan R; Perkins L; Phillips B; Schoenleber R; Scott WJ; Sheeler R; Redman A; Sun X; Taylor I; Wang L; Wilhelm S; Zhang X; Zhang M; Sullivan E; Carter C; Miglarese M; Levy J
    Bioorg Med Chem Lett; 2007 Aug; 17(15):4378-81. PubMed ID: 17574417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting signal transduction.
    Weber G; Shen F; Orbán TI; Kökeny S; Olah E
    Adv Enzyme Regul; 2003; 43():47-56. PubMed ID: 12791381
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis and biological evaluation of amide derivatives of diflunisal as potential anti-tumor agents.
    Zhong GX; Chen LL; Li HB; Liu FJ; Hu JQ; Hu WX
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4399-402. PubMed ID: 19515562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tessaric acid derivatives induce G2/M cell cycle arrest in human solid tumor cell lines.
    León LG; Donadel OJ; Tonn CE; Padrón JM
    Bioorg Med Chem; 2009 Sep; 17(17):6251-6. PubMed ID: 19664930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.